Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-05-20 @ 4:15 AM
Study NCT ID:
NCT05303402
Status:
COMPLETED
Last Update Posted:
2025-09-16
First Post:
2022-03-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.
Sponsor:
Hipra Scientific, S.L.U
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HIPRA-HH-4
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None